SDC4 and cardiomyopathy: To further characterize the syndecan-4–MLP interaction sites, MLP oligomerization, and the effect of human cardiomyopathy-associated MLP mutations, we have presently explored MLP, syndecan-4, and their interaction in adult primary rat cardiomyocytes and the H9c2 rat cardiomyoblast cell line.